SEC Form 4 · accession 0001108501-26-000002
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ray Kurzweil
Director
Period of report
Jul 9, 2026
Accepted (ET)
Jul 13, 2026 · 4:36 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 9, 2026 | M | 650 | $0.00 | A | 13,320 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | $0.00 | Jul 9, 2026 | M | 650 | D | Jul 9, 2026 | — | Common Stock | 650 | 0 | D |
Explanation of responses
- F1Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock.
- F2Not applicable as restricted stock units do not have an expiration date.